A PYMNTS Company

EU: Baxter, Gambro dialysis merger to clear following major divesture

By  |  July 10, 2013

A merger between US-based healthcare conglomerate Baxter and Sweden-based medical technologies company Gambro will be cleared by the European Commission, say reports. The agreement, signed at $4 billion, was modified when Baxter agreed to divest part of the company worth about one-fifth of its annual turnover, said two unnamed sources. Clearance from the European Commission would make the company the second-largest dialysis equipment manufacturer; reports say the global market is set to grow as obesity and diabetes rates climb. The two companies announced the deal last December.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    Full Content: Chicago Tribune

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.